Growth Metrics

Bespoke Extracts (BSPK) Common Equity (2017 - 2025)

Bespoke Extracts' Common Equity history spans 9 years, with the latest figure at -$2.6 million for Q3 2025.

  • For Q3 2025, Common Equity fell 11.42% year-over-year to -$2.6 million; the TTM value through Sep 2025 reached -$2.6 million, down 11.42%, while the annual FY2024 figure was -$2.1 million, 21.3% down from the prior year.
  • Common Equity for Q3 2025 was -$2.6 million at Bespoke Extracts, down from -$2.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $2.0 million in Q1 2022 and bottomed at -$2.6 million in Q3 2025.
  • The 5-year median for Common Equity is -$1.3 million (2023), against an average of -$930336.6.
  • The largest annual shift saw Common Equity skyrocketed 111.92% in 2021 before it plummeted 200.26% in 2023.
  • A 5-year view of Common Equity shows it stood at -$79724.0 in 2021, then tumbled by 743.03% to -$672096.0 in 2022, then tumbled by 156.59% to -$1.7 million in 2023, then fell by 21.3% to -$2.1 million in 2024, then fell by 24.07% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for BSPK's Common Equity are -$2.6 million (Q3 2025), -$2.5 million (Q2 2025), and -$2.3 million (Q1 2025).